Creative Medical Technology receives Nasdaq notice over minimum bid price noncompliance
CELZ•Creative Medical Technology Holdings received a Nasdaq notice on November 10 for failing to meet the $1 minimum bid-price requirement. It has until May 10, 2027, to regain compliance, with no immediate effect on its listing.
1. Compliance deadline
Creative Medical Technology Holdings said its common stock closed below $1 for 30 consecutive business days, violating Nasdaq Rule 5550(a)(2). The notice has no immediate listing impact. The company has 180 days, until May 10, 2027, to regain compliance by closing at $1 or more for at least 10 consecutive business days. Nasdaq may grant an additional 180-day extension if the company meets the Nasdaq Capital Market’s initial listing standards, excluding the minimum bid-price requirement.
